EKTA B Stock Overview
A medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 3/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Elekta AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr86.95 |
| 52 Week High | kr90.00 |
| 52 Week Low | kr70.00 |
| Beta | 1.02 |
| 1 Month Change | 14.41% |
| 3 Month Change | 15.17% |
| 1 Year Change | 4.76% |
| 3 Year Change | -24.49% |
| 5 Year Change | -31.16% |
| Change since IPO | 536.22% |
Recent News & Updates
Elekta AB (publ) (STO:EKTA B) Shares Could Be 29% Below Their Intrinsic Value Estimate
May 12
When Should You Buy Elekta AB (publ) (STO:EKTA B)?
Apr 03Is Elekta (STO:EKTA B) A Risky Investment?
Mar 18Recent updates
Elekta AB (publ) (STO:EKTA B) Shares Could Be 29% Below Their Intrinsic Value Estimate
May 12When Should You Buy Elekta AB (publ) (STO:EKTA B)?
Apr 03Is Elekta (STO:EKTA B) A Risky Investment?
Mar 18Elekta (STO:EKTA B) Is Paying Out A Dividend Of SEK1.20
Feb 22Why Investors Shouldn't Be Surprised By Elekta AB (publ)'s (STO:EKTA B) P/E
Feb 20Return Trends At Elekta (STO:EKTA B) Aren't Appealing
Feb 08Elekta AB (publ)'s (STO:EKTA B) Intrinsic Value Is Potentially 37% Above Its Share Price
Jan 03Elekta (STO:EKTA B) Will Pay A Dividend Of SEK1.20
Dec 18Elekta (STO:EKTA B) Is Due To Pay A Dividend Of SEK1.20
Dec 01Elekta (STO:EKTA B) Has Affirmed Its Dividend Of SEK1.20
Nov 11Elekta (STO:EKTA B) Has Some Way To Go To Become A Multi-Bagger
Nov 09Elekta (STO:EKTA B) Will Pay A Dividend Of SEK1.20
Oct 28Is Now The Time To Look At Buying Elekta AB (publ) (STO:EKTA B)?
Oct 26Elekta (STO:EKTA B) Has Affirmed Its Dividend Of SEK1.20
Oct 14An Intrinsic Calculation For Elekta AB (publ) (STO:EKTA B) Suggests It's 41% Undervalued
Sep 23Elekta (STO:EKTA B) Is Due To Pay A Dividend Of SEK1.20
Sep 08Elekta (STO:EKTA B) Has Announced A Dividend Of SEK1.20
Aug 25Elekta (STO:EKTA B) Has Announced A Dividend Of SEK1.20
Aug 10Is There Now An Opportunity In Elekta AB (publ) (STO:EKTA B)?
Jul 21Elekta (STO:EKTA B) Will Pay A Dividend Of SEK1.20
Jul 08Is There An Opportunity With Elekta AB (publ)'s (STO:EKTA B) 25% Undervaluation?
Jun 13Elekta (STO:EKTA B) Is Due To Pay A Dividend Of SEK1.20
May 28Here's Why Elekta (STO:EKTA B) Can Manage Its Debt Responsibly
Apr 02Investors Can Find Comfort In Elekta's (STO:EKTA B) Earnings Quality
Mar 04Elekta AB (publ)'s (STO:EKTA B) Intrinsic Value Is Potentially 57% Above Its Share Price
Feb 27Elekta's (STO:EKTA B) Shareholders Will Receive A Bigger Dividend Than Last Year
Feb 15Elekta (STO:EKTA B) Will Pay A Larger Dividend Than Last Year At SEK1.20
Feb 01What Does Elekta AB (publ)'s (STO:EKTA B) Share Price Indicate?
Jan 23These 4 Measures Indicate That Elekta (STO:EKTA B) Is Using Debt Reasonably Well
Dec 27Elekta's (STO:EKTA B) Upcoming Dividend Will Be Larger Than Last Year's
Dec 14Elekta (STO:EKTA B) Is Reinvesting At Lower Rates Of Return
Dec 09Elekta's (STO:EKTA B) Upcoming Dividend Will Be Larger Than Last Year's
Nov 23Elekta's (STO:EKTA B) Shareholders Will Receive A Bigger Dividend Than Last Year
Nov 09Elekta (STO:EKTA B) Will Pay A Larger Dividend Than Last Year At SEK1.20
Oct 26What Is Elekta AB (publ)'s (STO:EKTA B) Share Price Doing?
Oct 17Elekta's (STO:EKTA B) Dividend Will Be Increased To SEK1.20
Sep 19Elekta (STO:EKTA B) Has Announced That It Will Be Increasing Its Dividend To SEK1.20
Aug 28Is Elekta (STO:EKTA B) A Risky Investment?
Aug 22Elekta's (STO:EKTA B) Shareholders Will Receive A Bigger Dividend Than Last Year
Aug 08Elekta's (STO:EKTA B) Shareholders Will Receive A Bigger Dividend Than Last Year
Jul 10Return Trends At Elekta (STO:EKTA B) Aren't Appealing
Jul 07When Should You Buy Elekta AB (publ) (STO:EKTA B)?
Jun 23Elekta (STO:EKTA B) Seems To Use Debt Quite Sensibly
Apr 28Shareholder Returns
| EKTA B | SE Medical Equipment | SE Market | |
|---|---|---|---|
| 7D | 6.4% | 0.7% | 0.5% |
| 1Y | 4.8% | -8.2% | 18.6% |
Return vs Industry: EKTA B exceeded the Swedish Medical Equipment industry which returned -9.4% over the past year.
Return vs Market: EKTA B underperformed the Swedish Market which returned 16% over the past year.
Price Volatility
| EKTA B volatility | |
|---|---|
| EKTA B Average Weekly Movement | 3.8% |
| Medical Equipment Industry Average Movement | 6.7% |
| Market Average Movement | 5.9% |
| 10% most volatile stocks in SE Market | 13.2% |
| 10% least volatile stocks in SE Market | 3.5% |
Stable Share Price: EKTA B has not had significant price volatility in the past 3 months.
Volatility Over Time: EKTA B's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1972 | 4,584 | Gustaf Salford | elekta.com |
Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity for real-time MR visualization; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for image guided radiation therapy; treatment and workflow management solutions; radiation and medical oncology; and other patient services. It also provides Elekta Studio, an image guided brachytherapy solution; ImagingRing, a mobile CT scanner; Oncentra Brachy, a smart tool that facilitate repetitive tasks; Venezia applicator that enables the oncologist to treat locally advanced cervical cancer; Elekta Flexitron afterloader for enabling the precise execution of all steps in the workflow; Geneva, an applicator for cervical cancer treatment; veterinary radiation therapy products; and Elekta Kaiku for personalized cancer care.
Elekta AB (publ) Fundamentals Summary
| EKTA B fundamental statistics | |
|---|---|
| Market cap | kr33.22b |
| Earnings (TTM) | kr1.43b |
| Revenue (TTM) | kr18.22b |
23.2x
P/E Ratio1.8x
P/S RatioIs EKTA B overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| EKTA B income statement (TTM) | |
|---|---|
| Revenue | kr18.22b |
| Cost of Revenue | kr11.32b |
| Gross Profit | kr6.90b |
| Other Expenses | kr5.47b |
| Earnings | kr1.43b |
Last Reported Earnings
Jan 31, 2024
Next Earnings Date
Jun 05, 2024
| Earnings per share (EPS) | 3.75 |
| Gross Margin | 37.88% |
| Net Profit Margin | 7.86% |
| Debt/Equity Ratio | 57.2% |
How did EKTA B perform over the long term?
See historical performance and comparison